Royal London Asset Management Ltd. Acquires 5,478 Shares of Leidos Holdings, Inc. $LDOS

Royal London Asset Management Ltd. raised its holdings in Leidos Holdings, Inc. (NYSE:LDOS) by 93.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 11,365 shares of the aerospace company’s stock after buying an additional 5,478 shares during the period. Royal London Asset Management Ltd.’s holdings in Leidos were worth $1,170,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LDOS. Diamant Asset Management Inc. increased its position in shares of Leidos by 16,475.4% in the first quarter. Diamant Asset Management Inc. now owns 4,156,784 shares of the aerospace company’s stock valued at $646,463,000 after acquiring an additional 4,131,706 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Leidos by 1.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,421,634 shares of the aerospace company’s stock worth $256,463,000 after acquiring an additional 22,013 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in Leidos by 25,505.4% during the fourth quarter. New Age Alpha Advisors LLC now owns 42,505 shares of the aerospace company’s stock valued at $7,668,000 after purchasing an additional 42,339 shares during the last quarter. Norges Bank bought a new position in Leidos in the fourth quarter valued at approximately $318,839,000. Finally, Renaissance Technologies LLC bought a new position in Leidos in the first quarter valued at approximately $20,225,000. 76.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on LDOS. Wall Street Zen upgraded Leidos from a “hold” rating to a “buy” rating in a research note on Thursday, July 16th. Robert W. Baird set a $150.00 target price on shares of Leidos in a research note on Wednesday, August 5th. Royal Bank Of Canada lowered their target price on shares of Leidos from $180.00 to $170.00 and set an “outperform” rating on the stock in a report on Wednesday, August 5th. Truist Financial dropped their price target on shares of Leidos from $195.00 to $160.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. Finally, UBS Group increased their price target on shares of Leidos from $124.00 to $138.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $162.93.

Leidos Price Performance

NYSE:LDOS opened at $138.86 on Wednesday. The company has a quick ratio of 1.60, a current ratio of 1.63 and a debt-to-equity ratio of 1.13. The stock’s 50 day moving average price is $121.27 and its two-hundred day moving average price is $138.41. The firm has a market capitalization of $17.43 billion, a price-to-earnings ratio of 12.95, a P/E/G ratio of 2.04 and a beta of 0.56. Leidos Holdings, Inc. has a 12-month low of $98.86 and a 12-month high of $205.77.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, August 4th. The aerospace company reported $3.26 EPS for the quarter, topping the consensus estimate of $2.91 by $0.35. The company had revenue of $4.56 billion during the quarter, compared to the consensus estimate of $4.44 billion. Leidos had a return on equity of 30.81% and a net margin of 7.80%.The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $3.21 EPS. Leidos has set its FY 2026 guidance at 12.200-12.500 EPS. On average, analysts anticipate that Leidos Holdings, Inc. will post 12.38 earnings per share for the current year.

Leidos Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.43 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 1.2%. Leidos’s dividend payout ratio is presently 16.04%.

Leidos declared that its Board of Directors has authorized a share buyback program on Friday, July 31st that permits the company to buyback 20,000,000 outstanding shares. This buyback authorization permits the aerospace company to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity

In related news, Director Noel B. Geer sold 10,000 shares of Leidos stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $140.66, for a total transaction of $1,406,600.00. Following the completion of the sale, the director owned 34,274 shares of the company’s stock, valued at approximately $4,820,980.84. The trade was a 22.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.77% of the company’s stock.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.